Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Pre-market Movers For April 4 (PSDV, SRPT, CPWR, LULU)

Gainers:

pSivida Corp. (PSDV: Quote) is surging 19 percent to $2.70. The company announced that it has signed a funded technology evaluation agreement with a global pharmaceutical company to evaluate its proprietary Durasert and Tethadur technologies for select products in ophthalmology.

Sarepta Therapeutics, Inc. (SRPT) is up 3 percent to $35.11.

Decliners:

Compuware Corp. (CPWR: Quote) ia falling nearly 4 percent to $11.58 as the company warned that its fourth quarter results would come in way below Wall Street view due to delays in closing a large number of deals. The company also lowered its fiscal year 2013 revenue and earnings outlook.

Lululemon Athletica Inc. (LULU: Quote) is down nearly 1 percent to $63.75. The company announced that its Chief Product Officer Sheree Waterson will be leaving effective April 15. Last month, the company recalled its signature black Luon fabric yoga pants and crops from stores, showrooms and online website due to fabric quality issues.

Click here to receive FREE breaking news email alerts for Lululemon Athletica Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
A number of major retailers will be open on Thanksgiving for early Black Friday shopping events. Kohl's department stores will kick off Black Friday sales two hours earlier this year, at 6 p.m. Thanksgiving Day, while Macy's, Bon-Ton and Best Buy will open at the same time. J.C. Penney and Sears... Twitter Inc. has replaced its head of product Daniel Graf just six months after luring him over from Google, according to multiple reports. Graf, previously known for his work leading Google Maps, will retain his vice president of product title and work on Twitter's geolocation features, the Wall... LinkedIn Corp., the world's largest online professional network, said Thursday after the markets closed that its third quarter loss widened slightly from last year, as higher costs and expenses more than offset a 45% increase in revenue. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.